Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING
GLOBETECH PUBLISHING
PZ HTL SA

In Other News

Channels

Drug Discovery

view channel

New Drug Shown to Reduce Size in Both Injected and Metastasized Melanoma Tumors

A retrospective analysis of patients with metastatic melanoma revealed that a new pharmaceutical agent was shown to reduce the size of injected tumors and also non-injected tumors that had metastasized to other regions of the body. The analysis documented tumor-level responses from a pivotal phase 3 study evaluating... Read more

Biochemistry

view channel

Mitochondrial Cause of Aging Can Be Reversed

Researchers have found a cause of aging in lab animals that can be reversed, possibly providing an avenue for new treatments for age-related diseases including type 2 diabetes, cancer, muscle wasting, and inflammatory diseases. The researchers plan to begin human trials late 2014. The study, which was published December... Read more

Therapeutics

view channel

Cytokine Identified That Causes Mucositis in Cancer Therapy Patients

The action of the cytokine interleukin 1-beta (IL-1beta) has been found to underlie the onset of mucositis, a common, severe side effect of chemotherapy and irradiation of cancer patients. Mucositis occurs as a result of cell death in reaction to chemo- or radiotherapy. The mucosal lining of the mouth becomes thin, may... Read more

Lab Technologies

view channel
Image: b-screen is a versatile biomolecular interaction analysis tool for biomolecular arrays in standard microscope format (Photo courtesy of Biametrics GmbH).

Complementary Biomolecular Analysis Instruments Available for Research and Clinical Labs

Two new instruments for biomolecular analysis feature coated sensor chips (microarray format and mini format respectively) and assay protocols ready to support almost any research and development application... Read more

Business

view channel

Sonrgy in Licensing Agreement with UC San Diego for Drug Delivery Nanotech

Sonrgy, Inc. (San Diego, CA, USA), a biotechnology company developing focused drug delivery technologies, has obtained an exclusive license agreement with the University of California (UC; USA) for the company’s core technology, an ultrasound-sensitive drug delivery platform. The agreement gives the company the sole... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.